What is A Biomarker, and What Do They Tell Us About Mesothelioma?

When it comes to diagnosing malignant mesothelioma, physicians have several tools available. Doctors rely on the information that their patients provide about their history of exposure to asbestos, as well as the symptoms that they display, and based upon that information they order imaging studies, blood tests and biopsies. While X-rays and cat scans look

Defoe Shipbuilding Company

Situated in Bay City, Michigan, along the Saginaw River, Defoe Shipbuilding Company was one of the smaller-sized vessel repair and construction yards during World War II. While the shipyard helped the U.S. Navy and the war effort, workers often experienced exposure to asbestos on the job. The History of the Defoe Shipbuilding Company Initially known

Baylor’s Mesothelioma Treatment Center Announces New Clinical Trial

One of the shining lights in mesothelioma research can be found at the Baylor College of Medicine Lung Institute, where the Houston-based center’s Mesothelioma Treatment Center has long been on the cutting edge of both research and patient care. Now their associate professor of surgery Dr. Bryan Burt is taking their investigations one step further,

Japanese Study Shows P/D Surgery for Mesothelioma Offers Survival Advantage Over EPP

When a patient is diagnosed with malignant mesothelioma, they almost immediately sit down with their care team to create a care plan. With the treatments currently available, that plan is likely to include chemotherapy, and if possible it will include either extra pleural  pneumonectomy (EPP) surgery or pleurectomy with decortication (P/D) surgery, with the latter

BDNF Protein Linked to Poor Mesothelioma Prognosis

A protein that is found in the brain and other tissues has been linked directly to malignant mesothelioma, making it easier for physicians to diagnose the condition, as well as to craft a tailored course of treatment and set expectations for patients as to their prognosis. The protein is a biomarker known as BDNF, or

Jury Orders J & J to Pay $25 Million to Woman With Malignant Mesothelioma

A New York jury has awarded $25 million in compensatory damages to a 66-year-old woman who blames their talc-based baby powder product for her malignant mesothelioma. Donna Olson and her husband Robert filed their lawsuit in 2017, indicating that she had used both Johnson & Johnson’s Baby Powder and their scented Shower to Shower product

Talc Pleurodesis Mesothelioma Patients Need Revised Imaging Approach

One of the most common treatment protocols used to ease symptoms for patients diagnosed with malignant mesothelioma is a procedure known as talc pleurodesis. The treatment addresses the discomfort and breathing difficulties caused by pleural effusions, a build-up of fluid around the lungs. This buildup causes tremendous pressure and makes it nearly impossible for patients

“Count Me In” Project May Hold Promise For Mesothelioma Research

In the quest to find a cure for malignant mesothelioma, one of the biggest obstacles that researchers encounter is the lack of patient sample information available to those outside of major cities and cancer research centers. One potential solution lies in the efforts of Nikhil Wagle, a medical oncologist out of Dana-Farber Cancer Institute and

Rare Case of Testicular Mesothelioma Leads to $25 Million Jury Award

Malignant mesothelioma is one of the rarest forms of cancer, and  testicular mesothelioma is rarer still. Like other forms of mesothelioma, it is caused by exposure to asbestos. Though a company accused of responsibility for a former oil refinery worker’s testicular cancer attempted to contest this known fact, a California jury rejected their argument and

Get Help Contacting Mesothelioma.net
This field is for validation purposes and should be left unchanged.
24/7 Live Chat
Online Now